Skip to main content
. 2018 Apr 12;15(6):4599–4614. doi: 10.3892/etm.2018.6053

Table I.

Primary antibodies used in the current study.

Antibody Type Species Targeted species Dilution ratio (western blot/IHC) Supplier Catalog number
β-actin Mono M H, M, R 1:1,000 CST #3700
IL-1β Mono R M 1:1,000 CST #12507
IL-6 Poly R H, M, R 1:1,000/1:200 PT 21865-1-AP
TNF-α Mono M H, M, R 1:1,000/1:200 PT 60291-1-Ig
Bcl-2 Mono M H, M 1:500/1:200 Ab ab692
Bax Poly R H, M, R 1:1,000/1:200 PT 60267-1-Ig
Caspase-3 Poly R H, M, R 1:1,000 PT 19677-1-AP
Caspase-9 Mono M H, M, R 1:1,000 PT 66169-1-Ig
Beclin-1 Poly R H, M, R 1:1,000/1:200 PT 11306-1-AP
LC3 Poly R H, M, R 1:500/1:200 PT 14600-1-AP
p62 Poly R H, M, R 1:1,000 PT 55274-1-AP
PI3K Poly R H, M, R 1:1,000/1:200 PT 20584-1-AP
Akt Mono M H, M, R 1:2,000 PT 60203-2-Ig
p-Akt Mono M H, M, R 1:1,000/1:200 PT 66444-1-Ig

IHC, immunohistochemistry; IL, interleukin; TNF, tumor necrosis factor; Bcl-2, B-cell lymphoma-2; Bax, Bcl-2 associated X protein; LC3, microtubule-associated protein 1A/1B-light chain 3; PI3K, phosphoinositide 3-kinase; p-, phosphorylated; H, human; M, mouse; R, rabbit; CST, Cell Signaling Technology, Inc. (Danvers, MA, USA); PT, ProteinTech Group, Inc. (Chicago, IL, USA); Ab, Abcam (Cambridge, MA, USA).